Andrew J. Saxon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew J. Saxon has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- Kevin A. Hallgren
Department of Psychiatry and Behavioral Sciences University of Washington Seattle Washington USA
6 shared publications - Mark H. Duncan
Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, United States
6 shared publications - Yih-Ing Hser
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA
5 shared publications - Elizabeth Evans
Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, USA
4 shared publications - Matthew Iles-Shih
Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, United States
4 shared publications - Yanni Chang
Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, United States
4 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 183
Relationships between cannabis and cocaine use in a randomized trial of combined buprenorphine and naltrexone for DSM-IV cocaine dependence
- 29 July 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 183
Open AccessRelationships between cannabis and cocaine use in a randomized trial of combined buprenorphine and naltrexone for DSM-IV cocaine dependence
- Open Access
- 26 June 2026
- Published by Elsevier in Drug and Alcohol Dependence Reports
- Vol. 20
Relationship between depression on cocaine craving over time amongst patients in a trial evaluating the use of buprenorphine on cocaine use
- 26 June 2026
- Published by Elsevier in Drug and Alcohol Dependence Reports
- Vol. 20
Open AccessRelationship between depression on cocaine craving over time amongst patients in a trial evaluating the use of buprenorphine on cocaine use
- Open Access
- 19 February 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e80808
Smartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives
Background: Methamphetamine use disorder is a growing public health crisis with limited access to effective treatment. Contingency management (CM) has demonstrated efficacy for stimulant use disorders, but is typically delivered in person. Smartphone-based CM may overcome barriers such as limited access, but its effectiveness and real-world application remain understudied. This study explores patient and clinician experiences with a fully remote, smartphone-based CM intervention for methamphetamine use. Objective: This exploratory, descriptive qualitative study analyzes interviews with patients and clinicians involved in a previously published single-arm trial in which smartphone-based CM was offered to individuals using methamphetamine through primary care or specialty addiction treatment clinics within a large health system. The study aims to identify and describe key facilitators, barriers, and perspectives related to engagement of both groups with the intervention, providing actionable insights to inform optimization and implementation of digital CM in health care settings. Methods: We conducted a qualitative analysis of semistructured interviews with 14 patients and 14 clinicians from a prior pilot study of a fully remote, smartphone-based CM intervention for methamphetamine use. Interviews were analyzed using grounded theory in a 5-step process: transcript review, codebook development, coding, thematic reduction, and generation of overarching themes. The analysis focused on a priori themes related to facilitators, barriers, and suggestions for improvement. Results: Patients and clinicians identified many benefits, viewing the program as valuable for individuals using methamphetamine. Patients appreciated the flexibility, accessibility, and motivational incentives. Clinicians saw CM as a low-risk, evidence-based strategy that could enhance engagement, especially among patients less responsive to traditional approaches. Common challenges included technological issues such as problems with video-based testing, app navigation, and internet access. Patients had mixed views about educational modules and described difficulty with correct substance test procedures and a lack of human connection. Clinicians expressed concerns for patients with significant psychosocial instability. Differences emerged in the types of concerns raised: patients focused on day-to-day engagement, while clinicians emphasized broader themes of equity, sustainability, and a preference for models rewarding improvement even without full abstinence. Conclusions: Smartphone-based CM shows promise for addressing methamphetamine use disorder, especially in settings lacking traditional treatment access. However, optimizing implementation requires addressing challenges related to technology, accessibility, and equity. Recommendations include integrating CM with clinical infrastructure, expanding rewardable behaviors beyond abstinence, enhancing user experience, and improving technological access. Future research should explore flexible models that incorporate broader recovery goals and strengthen both technical and human support.
- 19 February 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e80808
Open AccessSmartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives
Background: Methamphetamine use disorder is a growing public health crisis with limited access to effective treatment. Contingency management (CM) has demonstrated efficacy for stimulant use disorders, but is typically delivered in person. Smartphone-based CM may overcome barriers such as limited access, but its effectiveness and real-world application remain understudied. This study explores patient and clinician experiences with a fully remote, smartphone-based CM intervention for methamphetamine use. Objective: This exploratory, descriptive qualitative study analyzes interviews with patients and clinicians involved in a previously published single-arm trial in which smartphone-based CM was offered to individuals using methamphetamine through primary care or specialty addiction treatment clinics within a large health system. The study aims to identify and describe key facilitators, barriers, and perspectives related to engagement of both groups with the intervention, providing actionable insights to inform optimization and implementation of digital CM in health care settings. Methods: We conducted a qualitative analysis of semistructured interviews with 14 patients and 14 clinicians from a prior pilot study of a fully remote, smartphone-based CM intervention for methamphetamine use. Interviews were analyzed using grounded theory in a 5-step process: transcript review, codebook development, coding, thematic reduction, and generation of overarching themes. The analysis focused on a priori themes related to facilitators, barriers, and suggestions for improvement. Results: Patients and clinicians identified many benefits, viewing the program as valuable for individuals using methamphetamine. Patients appreciated the flexibility, accessibility, and motivational incentives. Clinicians saw CM as a low-risk, evidence-based strategy that could enhance engagement, especially among patients less responsive to traditional approaches. Common challenges included technological issues such as problems with video-based testing, app navigation, and internet access. Patients had mixed views about educational modules and described difficulty with correct substance test procedures and a lack of human connection. Clinicians expressed concerns for patients with significant psychosocial instability. Differences emerged in the types of concerns raised: patients focused on day-to-day engagement, while clinicians emphasized broader themes of equity, sustainability, and a preference for models rewarding improvement even without full abstinence. Conclusions: Smartphone-based CM shows promise for addressing methamphetamine use disorder, especially in settings lacking traditional treatment access. However, optimizing implementation requires addressing challenges related to technology, accessibility, and equity. Recommendations include integrating CM with clinical infrastructure, expanding rewardable behaviors beyond abstinence, enhancing user experience, and improving technological access. Future research should explore flexible models that incorporate broader recovery goals and strengthen both technical and human support.
- Open Access
- 28 November 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 278, 112993
Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment
- 28 November 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 278, 112993
Open AccessQuality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment
- Open Access
- 18 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Smartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives (Preprint)
BACKGROUND Methamphetamine use disorder is a growing public health crisis with limited access to effective treatment. Contingency management (CM) has demonstrated efficacy for stimulant use disorders, but is typically delivered in person. Smartphone-based CM may overcome barriers such as limited access, but its effectiveness and real-world application remain understudied. This study explores patient and clinician experiences with a fully remote, smartphone-based CM intervention for methamphetamine use. OBJECTIVE This exploratory, descriptive qualitative study analyzes interviews with patients and clinicians involved in a previously published single-arm trial in which smartphone-based CM was offered to individuals using methamphetamine through primary care or specialty addiction treatment clinics within a large health system. The study aims to identify and describe key facilitators, barriers, and perspectives related to engagement of both groups with the intervention, providing actionable insights to inform optimization and implementation of digital CM in health care settings. METHODS We conducted a qualitative analysis of semistructured interviews with 14 patients and 14 clinicians from a prior pilot study of a fully remote, smartphone-based CM intervention for methamphetamine use. Interviews were analyzed using grounded theory in a 5-step process: transcript review, codebook development, coding, thematic reduction, and generation of overarching themes. The analysis focused on a priori themes related to facilitators, barriers, and suggestions for improvement. RESULTS Patients and clinicians identified many benefits, viewing the program as valuable for individuals using methamphetamine. Patients appreciated the flexibility, accessibility, and motivational incentives. Clinicians saw CM as a low-risk, evidence-based strategy that could enhance engagement, especially among patients less responsive to traditional approaches. Common challenges included technological issues such as problems with video-based testing, app navigation, and internet access. Patients had mixed views about educational modules and described difficulty with correct substance test procedures and a lack of human connection. Clinicians expressed concerns for patients with significant psychosocial instability. Differences emerged in the types of concerns raised: patients focused on day-to-day engagement, while clinicians emphasized broader themes of equity, sustainability, and a preference for models rewarding improvement even without full abstinence. CONCLUSIONS Smartphone-based CM shows promise for addressing methamphetamine use disorder, especially in settings lacking traditional treatment access. However, optimizing implementation requires addressing challenges related to technology, accessibility, and equity. Recommendations include integrating CM with clinical infrastructure, expanding rewardable behaviors beyond abstinence, enhancing user experience, and improving technological access. Future research should explore flexible models that incorporate broader recovery goals and strengthen both technical and human support.
- 18 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessSmartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives (Preprint)
BACKGROUND Methamphetamine use disorder is a growing public health crisis with limited access to effective treatment. Contingency management (CM) has demonstrated efficacy for stimulant use disorders, but is typically delivered in person. Smartphone-based CM may overcome barriers such as limited access, but its effectiveness and real-world application remain understudied. This study explores patient and clinician experiences with a fully remote, smartphone-based CM intervention for methamphetamine use. OBJECTIVE This exploratory, descriptive qualitative study analyzes interviews with patients and clinicians involved in a previously published single-arm trial in which smartphone-based CM was offered to individuals using methamphetamine through primary care or specialty addiction treatment clinics within a large health system. The study aims to identify and describe key facilitators, barriers, and perspectives related to engagement of both groups with the intervention, providing actionable insights to inform optimization and implementation of digital CM in health care settings. METHODS We conducted a qualitative analysis of semistructured interviews with 14 patients and 14 clinicians from a prior pilot study of a fully remote, smartphone-based CM intervention for methamphetamine use. Interviews were analyzed using grounded theory in a 5-step process: transcript review, codebook development, coding, thematic reduction, and generation of overarching themes. The analysis focused on a priori themes related to facilitators, barriers, and suggestions for improvement. RESULTS Patients and clinicians identified many benefits, viewing the program as valuable for individuals using methamphetamine. Patients appreciated the flexibility, accessibility, and motivational incentives. Clinicians saw CM as a low-risk, evidence-based strategy that could enhance engagement, especially among patients less responsive to traditional approaches. Common challenges included technological issues such as problems with video-based testing, app navigation, and internet access. Patients had mixed views about educational modules and described difficulty with correct substance test procedures and a lack of human connection. Clinicians expressed concerns for patients with significant psychosocial instability. Differences emerged in the types of concerns raised: patients focused on day-to-day engagement, while clinicians emphasized broader themes of equity, sustainability, and a preference for models rewarding improvement even without full abstinence. CONCLUSIONS Smartphone-based CM shows promise for addressing methamphetamine use disorder, especially in settings lacking traditional treatment access. However, optimizing implementation requires addressing challenges related to technology, accessibility, and equity. Recommendations include integrating CM with clinical infrastructure, expanding rewardable behaviors beyond abstinence, enhancing user experience, and improving technological access. Future research should explore flexible models that incorporate broader recovery goals and strengthen both technical and human support.
- 8 March 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 138, 104765
Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients
- 8 March 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 138, 104765
Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients
- 1 May 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (5) , e2411398
Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era
The study conveyed by Min et al grew out of the fact that, during the early part of the COVID-19 pandemic, British Columbia allowed the dispensation of
- 1 May 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (5) , e2411398
Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era
The study conveyed by Min et al grew out of the fact that, during the early part of the COVID-19 pandemic, British Columbia allowed the dispensation of
- Open Access
- 13 July 2023
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 10 (1) , e42654
Workload, Usability, and Engagement with a Mobile App Supporting Video Observation of Methadone Take-Home Dosing: Usability Study
Background: Methadone, a cornerstone of opioid use disorder treatments for many decades, is an essential tool for combatting the opioid epidemic. However, requirements for observing methadone dosing in person through direct observed therapy (DOT) impose significant barriers for many patients. Digital technology can facilitate remote DOT, which could reduce barriers to methadone treatment. Currently, there are limited data on the usability of such technology among patients and counselors in methadone treatment settings. Objective: The primary objective of this study was to assess the workload, usability, and engagement of a video-based DOT mobile app for patients with opioid use disorder receiving methadone treatment. The secondary objective was to assess the workload, usability, and engagement of the provider-facing app portal used by counselors. Methods: Patients (n=12) and counselors (n=3) who previously tried video DOT for methadone through a smartphone app in an opioid treatment program participated in usability testing sessions. Participants completed essential tasks for video DOT, then provided ratings of workload (NASA Task Load Index), usability (modified System Usability Scale), and engagement (modified Engagement Scale) with the core features of the video DOT program Results: Patients and counselors reported low mental, physical, and temporal demands, successful performance, low effort, and low frustration associated with activities. Patients reported high usability (mean 85, SD 9.5) and engagement (mean 3.8, SD 1.1); counselors reported moderate usability (mean 43.3, SD 17.7) and engagement (mean 2.81, SD 0.63). Conclusions: A mobile health app that facilitates video-based DOT for methadone required a low workload for patients and counselors and was highly usable for patients in an opioid treatment program; however, there are opportunities to improve usability and engagement for the counselor-facing portal.
- 13 July 2023
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 10 (1) , e42654
Open AccessWorkload, Usability, and Engagement with a Mobile App Supporting Video Observation of Methadone Take-Home Dosing: Usability Study
Background: Methadone, a cornerstone of opioid use disorder treatments for many decades, is an essential tool for combatting the opioid epidemic. However, requirements for observing methadone dosing in person through direct observed therapy (DOT) impose significant barriers for many patients. Digital technology can facilitate remote DOT, which could reduce barriers to methadone treatment. Currently, there are limited data on the usability of such technology among patients and counselors in methadone treatment settings. Objective: The primary objective of this study was to assess the workload, usability, and engagement of a video-based DOT mobile app for patients with opioid use disorder receiving methadone treatment. The secondary objective was to assess the workload, usability, and engagement of the provider-facing app portal used by counselors. Methods: Patients (n=12) and counselors (n=3) who previously tried video DOT for methadone through a smartphone app in an opioid treatment program participated in usability testing sessions. Participants completed essential tasks for video DOT, then provided ratings of workload (NASA Task Load Index), usability (modified System Usability Scale), and engagement (modified Engagement Scale) with the core features of the video DOT program Results: Patients and counselors reported low mental, physical, and temporal demands, successful performance, low effort, and low frustration associated with activities. Patients reported high usability (mean 85, SD 9.5) and engagement (mean 3.8, SD 1.1); counselors reported moderate usability (mean 43.3, SD 17.7) and engagement (mean 2.81, SD 0.63). Conclusions: A mobile health app that facilitates video-based DOT for methadone required a low workload for patients and counselors and was highly usable for patients in an opioid treatment program; however, there are opportunities to improve usability and engagement for the counselor-facing portal.
- Open Access
- 6 July 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e47516
Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
Background: In the United States, methamphetamine-related overdoses have tripled from 2015 to 2020 and continue to rise. However, efficacious treatments such as contingency management (CM) are often unavailable in health systems. Objective: We conducted a single-arm pilot study to evaluate the feasibility, engagement, and usability of a fully remotely delivered mobile health CM program offered to adult outpatients who used methamphetamine and were receiving health care within a large university health system. Methods: Participants were referred by primary care or behavioral health clinicians between September 2021 and July 2022. Eligibility criteria screening was conducted by telephone and included self-reported methamphetamine use on ≥5 out of the past 30 days and a goal of reducing or abstaining from methamphetamine use. Eligible participants who agreed to take part then completed an initial welcome phase that included 2 videoconference calls to register for and learn about the CM program and 2 “practice” saliva-based substance tests prompted by a smartphone app. Participants who completed these welcome phase activities could then receive the remotely delivered CM intervention for 12 consecutive weeks. The intervention included approximately 24 randomly scheduled smartphone alerts requesting a video recording of themselves taking a saliva-based substance test to verify recent methamphetamine abstinence, 12 weekly calls with a CM guide, 35 self-paced cognitive behavioral therapy modules, and multiple surveys. Financial incentives were disbursed via reloadable debit cards. An intervention usability questionnaire was completed at the midpoint. Results: Overall, 37 patients completed telephone screenings, with 28 (76%) meeting the eligibility criteria and consenting to participate. Most participants who completed a baseline questionnaire (21/24, 88%) self-reported symptoms consistent with severe methamphetamine use disorder, and most had other co-occurring non-methamphetamine substance use disorders (22/28, 79%) and co-occurring mental health disorders (25/28, 89%) according to existing electronic health records. Overall, 54% (15/28) of participants successfully completed the welcome phase and were able to receive the CM intervention. Among these participants, engagement with substance testing, calls with CM guides, and cognitive behavioral therapy modules varied. Rates of verified methamphetamine abstinence in substance testing were generally low but varied considerably across participants. Participants reported positive opinions about the intervention’s ease of use and satisfaction with the intervention. Conclusions: Fully remote CM can be feasibly delivered within health care settings lacking existing CM programs. Although remote delivery may help reduce barriers to treatment access, many patients who use methamphetamine may struggle to engage with initial onboarding. High rates of co-occurring psychiatric conditions in the patient population may also contribute to uptake and engagement challenges. Future efforts could leverage greater human-to-human connection, more streamlined onboarding procedures, larger incentives, longer durations, and the incentivization of non–abstinence-based recovery goals to increase uptake and engagement with fully remote mobile health–based CM.
- 6 July 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e47516
Open AccessFeasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
Background: In the United States, methamphetamine-related overdoses have tripled from 2015 to 2020 and continue to rise. However, efficacious treatments such as contingency management (CM) are often unavailable in health systems. Objective: We conducted a single-arm pilot study to evaluate the feasibility, engagement, and usability of a fully remotely delivered mobile health CM program offered to adult outpatients who used methamphetamine and were receiving health care within a large university health system. Methods: Participants were referred by primary care or behavioral health clinicians between September 2021 and July 2022. Eligibility criteria screening was conducted by telephone and included self-reported methamphetamine use on ≥5 out of the past 30 days and a goal of reducing or abstaining from methamphetamine use. Eligible participants who agreed to take part then completed an initial welcome phase that included 2 videoconference calls to register for and learn about the CM program and 2 “practice” saliva-based substance tests prompted by a smartphone app. Participants who completed these welcome phase activities could then receive the remotely delivered CM intervention for 12 consecutive weeks. The intervention included approximately 24 randomly scheduled smartphone alerts requesting a video recording of themselves taking a saliva-based substance test to verify recent methamphetamine abstinence, 12 weekly calls with a CM guide, 35 self-paced cognitive behavioral therapy modules, and multiple surveys. Financial incentives were disbursed via reloadable debit cards. An intervention usability questionnaire was completed at the midpoint. Results: Overall, 37 patients completed telephone screenings, with 28 (76%) meeting the eligibility criteria and consenting to participate. Most participants who completed a baseline questionnaire (21/24, 88%) self-reported symptoms consistent with severe methamphetamine use disorder, and most had other co-occurring non-methamphetamine substance use disorders (22/28, 79%) and co-occurring mental health disorders (25/28, 89%) according to existing electronic health records. Overall, 54% (15/28) of participants successfully completed the welcome phase and were able to receive the CM intervention. Among these participants, engagement with substance testing, calls with CM guides, and cognitive behavioral therapy modules varied. Rates of verified methamphetamine abstinence in substance testing were generally low but varied considerably across participants. Participants reported positive opinions about the intervention’s ease of use and satisfaction with the intervention. Conclusions: Fully remote CM can be feasibly delivered within health care settings lacking existing CM programs. Although remote delivery may help reduce barriers to treatment access, many patients who use methamphetamine may struggle to engage with initial onboarding. High rates of co-occurring psychiatric conditions in the patient population may also contribute to uptake and engagement challenges. Future efforts could leverage greater human-to-human connection, more streamlined onboarding procedures, larger incentives, longer durations, and the incentivization of non–abstinence-based recovery goals to increase uptake and engagement with fully remote mobile health–based CM.
- 2 May 2023
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 248, 109902
Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration
- 2 May 2023
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 248, 109902
Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration